[Federal Register Volume 84, Number 166 (Tuesday, August 27, 2019)]
[Notices]
[Pages 44908-44909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18383]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; The Experimental Therapeutics Clinical Trials Network (UM1/
U24).
Date: September 23-24, 2019.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Klaus B. Piontek, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, 9609 Medical Center Drive, Room 7W116, National Cancer
Institute, Rockville, MD 20892-9750, 240-276-5413,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SPORE I (P50).
Date: September 26-27, 2019.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Majed M. Hamawy, Ph.D., MBA, Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center Dr.,
Rm 7W120, Bethesda, MD 20892, 240-276-6457, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-2: Small Grants Program for Cancer Research (Omnibus
R03).
Date: October 4, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Rockville, MD 20850, 240-276-7286, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Quantitative Imaging Tools and Co-Clinical Imaging Resources.
Date: October 11, 2019.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Rockville, MD 20850, 240-276-7684, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Optimizing the Management & Outcomes for Cancer Survivors.
Date: October 15, 2019.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W240, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Hasan Siddiqui, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W240, Rockville, MD 20850, 240-276-5122, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Program Project III.
Date: October 16-17, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Jennifer C. Schiltz, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, Nation Institutes of Health, Rockville,
MD 20850, 240-276-5864, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Assay Validation of High Quality Markers for Clinical Studies
in Cancer.
Date: October 17, 2019.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Rockville, MD 20850, 240-276-7684, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-3: Small Grants Program for Cancer Research (Omnibus
R03).
Date: October 22, 2019.
Time: 7:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Hasan Siddiqui, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W240, Rockville, MD 20850, 240-276-5122, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Biospecimen Science Approaches.
Date: November 6, 2019.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W234, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W234, Bethesda, MD 20892-9750, 240-276-6368,
[email protected].
[[Page 44909]]
Name of Committee: National Cancer Institute Special Emphasis
Panel; Innovative Molecular and Cellular Analysis Technologies.
Date: November 7, 2019.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology & Contract Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W246, Rockville, MD 20850, (240) 276-5460,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: August 21, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-18383 Filed 8-26-19; 8:45 am]
BILLING CODE 4140-01-P